Metagenomi

Discovering the next generation of gene-editing systems for use in treating genetic diseases

Launch date

2018

Employees

Ownership

Firm valuation

Emeryville California (HQ)

Date	Investors	Amount	Round
Feb 2019	Jeremy Yap	N/A	Seed Not yet verified
Aug 2019	N/A	$26.4m	Series A Not yet verified
Nov 2020	InCube Ventures Bayer HOF Capital Sozo Ventures Agent Capital Leaps by Bayer Humboldt Fund	$65m	Series A
Apr 2021	InCube Ventures HOF Capital Sozo Ventures RA Capital Management Agent Capital Leaps by Bayer Humboldt Fund	$10m Valuation: $325m	Series A
Jan 2022*	Farallon Capital Management Moderna Therapeutics Bristol-Myers Squibb Novo Holdings Frazier Healthcare Partners PFM Health Sciences Eventide Asset Management RA Capital Management Pura Vida Investments Irving Investors Marshall Wace Millennium Management Leaps by Bayer Humboldt Fund Surveyor Capital Deep Track Capital	$175m	Series B
Total Funding		$250m

Tech stackLearn more about the technologies and tools that this company uses.

Metagenomi funding